Biblio

Found 25 results
Author Keyword [ Title(Desc)] Type Year
Filters: Author is Mahesh K B Parmar  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
F. A. Raja, Griffin, C. L., Qian, W., Hirte, H., Parmar, M. K. B., Swart, A. Marie, and Ledermann, J. A., Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer., Br J Cancer, vol. 105, no. 7, pp. 884-9, 2011.
M. J. Piccart, Stuart, G. C. E., Cassidy, J., Bertelsen, K., Parmar, M. K. B., Eisenhauer, E., Kaye, S. B., Tropé, C. G., Swenerton, K. D., Harper, P., and Vermorken, J. B., Intergroup collaboration in ovarian cancer: a giant step forward., Ann Oncol, vol. 10 Suppl 1, pp. 83-6, 1999.
N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., Bonazzi, C., and Collaborators, I. Collaborat, International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer, J Natl Cancer Inst, vol. 95, pp. 125-32, 2003.
N. Colombo, Guthrie, D., Chiari, S., Parmar, M. K. B., Qian, W., Swart, A. Marie, Torri, V., Williams, C., Lissoni, A., and Bonazzi, C., International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer., J Natl Cancer Inst, vol. 95, no. 2, pp. 125-32, 2003.
J. B. Trimbos, Parmar, M. K. B., Vergote, I. B., Guthrie, D., Bolis, G., Colombo, N., Vermorken, J. B., Torri, V., Mangioni, C., Pecorelli, S., Lissoni, A., Swart, A. Marie, Neoplasm, I. Collaborat, Research, E. Organisati, and Neoplasm, Tof Cancer, International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma, J Natl Cancer Inst, vol. 95, pp. 105-12, 2003.
P
M. K. B. Parmar, Ledermann, J. A., Colombo, N., du Bois, A., Delaloye, J. F., Kristensen, G. B., Wheeler, S., Swart, A. Marie, Qian, W., Torri, V., Floriani, I., Jayson, G. C., Lamont, A., Tropé, C. G., ,, and Collaborators, A. G. O., Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial, Lancet, vol. 361, pp. 2099-106, 2003.
M. K. B. Parmar, Ledermann, J. A., Colombo, N., du Bois, A., Delaloye, J. - F., Kristensen, G. B., Wheeler, S., Swart, A. Marie, Qian, W., Torri, V., Floriani, I., Jayson, G. C., Lamont, A., and Tropé, C. G., Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial., Lancet, vol. 361, no. 9375, pp. 2099-106, 2003.
T. J. Perren, Swart, A. Marie, Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R., Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., and Oza, A. M., A phase 3 trial of bevacizumab in ovarian cancer., N Engl J Med, vol. 365, no. 26, p. 2496, 2011.
F. A. Raja, Counsell, N., Colombo, N., Pfisterer, J., du Bois, A., Parmar, M. K. B., Vergote, I. B., Gonzalez-Martin, A., Alberts, D. S., Plante, M., Torri, V., and Ledermann, J. A., Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data., Ann Oncol, vol. 24, no. 12, pp. 3028-34, 2013.